No.
CXO didn't spend any cash, but issued CXO shares of approx. $500K valuation to LIT for 10% of the entire CHR share register - all projects.
They then have the right (assuming CHR do not take their pre-emptive right) to take 30% of Bynoe for a further cash consideration of $500K.
Thereby valuing Bynoe project itself, at around $1.5M.
I guess CHR will be looking hard for Niobium to keep the SP elevated. If they have success and rocket, that's cool too as CXO will make money having paid around 7 cents per CHR share (based on CXO current SP) for their 10% holding.
- Forums
- ASX - By Stock
- CHR
- Ann: CXO: Strategic Inv.in Charger Metals and the Bynoe Project
Ann: CXO: Strategic Inv.in Charger Metals and the Bynoe Project, page-21
Featured News
Add CHR (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.6¢ |
Change
0.001(1.33%) |
Mkt cap ! $5.883M |
Open | High | Low | Value | Volume |
7.6¢ | 7.6¢ | 7.6¢ | $1.369K | 18.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 18564 | 7.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.8¢ | 27973 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 18564 | 0.076 |
2 | 59809 | 0.075 |
1 | 20000 | 0.073 |
1 | 10000 | 0.072 |
2 | 21830 | 0.071 |
Price($) | Vol. | No. |
---|---|---|
0.078 | 27973 | 3 |
0.085 | 13333 | 1 |
0.098 | 161249 | 1 |
0.099 | 72000 | 2 |
0.100 | 250000 | 1 |
Last trade - 15.08pm 15/11/2024 (20 minute delay) ? |
Featured News
CHR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online